Pressurised metered dose inhaler v dry powder inhaler for delivering corticosteroids in asthma (parallel studies only)*

Outcomes at ≥ 4 weeksNumber of studies (n)SMD (95% CI)
*SMD = standardised mean difference; minus sign means results favour the dry powder inhaler. A fixed effects model was used.
FEV17 (1404)–0.14 (–0.25 to –0.03)
Morning peak expiratory flow rate7 (1389)–0.14 (–0.25 to –0.04)
Use of additional relief drugs6 (967)–0.18 (–0.31 to –0.05)